CNPY2 is key regulator of different types of human cancer such as renal cell carcinoma [24], colorectal cancer [25], non-small cell lung cancer [26], and lung adenocarcinoma [27]. This evidence concerns the gene CNPY2 and hereditary clear cell renal cell carcinoma.